Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials (Q47675542)

4 February 2018

review article

1 reference

title

Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials (English)

1 reference

4 February 2018

coronary artery bypass surgery

main subject

1 reference

C W White

1

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

4 February 2018

American Journal of Medicine

published in

1 reference

4 February 2018

volume

105

1 reference

4 February 2018

issue

1A

1 reference

4 February 2018

page(s)

63S-68S

1 reference

4 February 2018

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Range of serum cholesterol values in the population developing coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Cholesterol reduction and its impact on coronary artery disease and total mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

Lipid-lowering interventions in angiographic trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

The influence of pretreatment low density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials. Harvard Atherosclerosis Reversibility Project Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

The value of lowering cholesterol after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900214-9

10.1016/S0002-9343(98)00214-9

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

9707270

1 reference

4 February 2018